King Charles shared his cancer diagnosis in February 2024 after undergoing a procedure for an enlarged prostate and has ...
Arcus ends its Phase 3 STAR-221 trial after a futility review and shifts R&D toward casdatifan, supported by strong early RCC ...
GLP-1 RAs probably have little or no effect on risk for thyroid cancer, pancreatic cancer, breast cancer, or kidney cancer.
Gilead Sciences and Arcus Biosciences said on Friday they would stop a late-stage study testing their experimental cancer ...
Shares in biopharmaceutical company Arcus Biosciences ($RCUS) collapsed 17% in pre-market trading after it said it was ...
As a kidney transplant recipient, Paris Malachias was accustomed to dealing with skin cancer. But when a biopsy showed that ...
A systematic review and meta-analysis evaluated the risk for obesity-related cancer associated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) in patients with type 2 diabetes (T2D) or ...
In this episode of Florida Health Care Insider, presented by Cleveland Clinic in partnership with the South Florida Business ...
In 2023, the parents of Fabian Musembi were stunned when they learned that the right side of their baby's stomach was inflamed and he was later diagnosed with stomach cancer According to Vincent Mutua ...
DEAR MAYO CLINIC: My 39-year-old brother was just diagnosed with gastric cancer. The diagnosis was especially shocking because of his age. Is this becoming more common? Does age affect the approaches ...
Stomach cancer, also referred to as gastric cancer, was once thought of as a disease of older adults. However, it is increasingly affecting people under the age of 50, mirroring a similar shift that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results